Aflac (AFL) Projected to Post Quarterly Earnings on Wednesday

Aflac (NYSE:AFL) will likely be posting its quarterly earnings results after the market closes on Wednesday, February 5th. Analysts expect Aflac to post earnings of $1.63 per share and revenue of $4.16 billion for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Aflac (NYSE:AFL) last posted its earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.69 by $0.47. The company had revenue of $2.95 billion during the quarter, compared to analysts’ expectations of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. Aflac’s quarterly revenue was down 40.4% on a year-over-year basis. During the same period last year, the company posted $1.84 earnings per share. On average, analysts expect Aflac to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Aflac Stock Down 0.7 %

Shares of AFL stock opened at $107.39 on Wednesday. The stock has a market cap of $59.66 billion, a P/E ratio of 16.17, a PEG ratio of 2.10 and a beta of 1.00. The company’s fifty day simple moving average is $105.81 and its two-hundred day simple moving average is $106.15. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. Aflac has a 52 week low of $75.07 and a 52 week high of $115.50.

Aflac Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Wednesday, February 19th will be paid a dividend of $0.58 per share. The ex-dividend date of this dividend is Wednesday, February 19th. This is a positive change from Aflac’s previous quarterly dividend of $0.50. This represents a $2.32 dividend on an annualized basis and a yield of 2.16%. Aflac’s dividend payout ratio is presently 30.12%.

Insider Transactions at Aflac

In related news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the sale, the executive vice president now owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This represents a 10.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

AFL has been the topic of several recent research reports. Bank of America upped their price objective on Aflac from $115.00 to $124.00 and gave the stock a “buy” rating in a report on Thursday, October 10th. Piper Sandler boosted their target price on Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. BMO Capital Markets initiated coverage on Aflac in a research report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price target for the company. Truist Financial boosted their price objective on shares of Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Finally, Barclays upped their price target on shares of Aflac from $96.00 to $98.00 and gave the company an “underweight” rating in a report on Monday, January 6th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and three have given a buy rating to the company. According to MarketBeat.com, Aflac currently has an average rating of “Hold” and a consensus target price of $102.67.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.